GHIPPGlobal Health Innovation Policy Program

Language :

Global Dialogue on Health Security

Global Health Innovation Policy Program

Facing COVID-19 crisis, we are here to ensure healthy lives and promote well-being for all at all ages. In particular it is important to address healthcare resources and policies to prepare against health emergency crisis, through building a resilient global community.

GHIPP is organizing Global Dialogue on Health Security for strengthening global partnership through sharing knowledge and lessons learned and creating a new regional community for health resilience. Having a series of online speakers’ sessions, the project focuses on building collaborative Asia-US-Japan platform for knowledge & experience sharing, and discusses how to best prepare and lead dealing with future health crises.


#6 Dialogue on March 3, 2021   09:00-10:00 JST  (March 2, 2021   19:00-20:00 EST)

Topic: ”COVID-19 and Beyond: Presidents versus Pandemicide”

Speaker: Ms. Laurie Garrett, Pulitzer Winner & Science journalist

Commentator: Dr. Kiyoshi Kurokawa (GHIPP)

Facilitator: Dr. Hiromi Murakami (GHIPP)

Language: English

Registration HERE(free) 

Laurie Garrett wrote her first bestselling book, THE COMING PLAGUE: Newly Emerging Diseases in a World Out of Balance, while splitting her time between the Harvard School of Public Health and the New York newspaper, Newsday. In the 1992-93 academic years Garrett was a Fellow at Harvard, where she worked closely with the emerging diseases group, a collection of faculty concerned about the surge in epidemics of previously unknown or rare viruses and bacteria. The book was published in hardcopy by Farrar, Straus, and Giroux in 1994, and spent 19 weeks on the New York Times bestseller list. Released in paperback in 1995 by Viking Penguin, THE COMING PLAGUE remains in print and continues to sell vigorously. The book was released in e-book form in May 2011. During the 1990s Garrett continued tracking outbreaks and epidemics worldwide, noting the insufficient responses from global public health institutions in Zaire, India, Russia and most of the former USSR, Eastern Europe, and the United States. This resulted in publication in 2000 of BETRAYAL OF TRUST: The Collapse of Global Public Health, released by Hyperion that year, and in paperback in 2001. BETRAYAL OF TRUST was also a vigorous seller, and remains in print today. It was also released as an e-book in May 2011. In Summer 2011 , Garrett’s long-awaited third book, I HEARD THE SIRENS SCREAM: How Americans Responded to the 9/11 and Anthrax Attacks, was published in time for the 10th Anniversary of 9/11 by Amazon as an e-book. It is also available on Kindle and in paperback. Garrett is a Member of the World Economic Forum Global Health Security Advisory Board. She is also a member of the Council on Foreign Relations, and the National Association for Science Writers. Garrett helped create the Noguchi Africa Prize and has three times served as its judge. Listed as a twice-ver “Cassandra”, in WARNINGS: Finding Cassandras to Stop Catastrophes (2017), Richard A. Clarke and R.P. Eddy, HarperCollins Publishers.

 

 


#5 Dialogue: January 26, 2021  17:00-18:00 JST

Topic: “COVID-19 and Beyond: Australian experience and effort to contain COVID-19″

Speaker: Dr. Sanjaya Senanayake (Infectious Disease Physician in Canberra and an Associate Professor of Medicine at the Australian National University (ANU) Medical School)Sanjaya_pico (147x200)

 

Commentator: Dr. Kiyoshi Kurokawa (GHIPP)

Facilitator: Dr. Hiromi Murakami (GHIPP)

Dialogue Video is available HERE.

 

Sanjaya Senanayake is an Infectious Disease Physician in Canberra and an Associate Professor of Medicine at the Australian National University (ANU) Medical School. He has an interest in epidemiology and infections of public health importance, and is a regulator commentator in the media on a range of public health issues including COVID-19. Dr Senanayake completed a Bachelor of Medical Science and Bachelor of Medicine and Surgery at the University of New South Wales, and Master of Applied Epidemiology from the ANU.

 


#4 Dialogue: January 14, 2021  17:00-18:00 JST (January 14, 2021  09:00-10:00am Geneva time)

Topic: “Global solidarity to end COVID-19 pandemic :  Progress and challenges” 

Speaker: Dr. Osamu Kunii (Head of Strategy, Investment and Impact Division of The Global Fund to Fight AIDS, Tuberculosis and Malaria)

Commentator: Dr. Kiyoshi Kurokawa (GHIPP)

Facilitator: Dr. Hiromi Murakami (GHIPP)

Language: English

Dialogue Video is available HERE.

 

Osamu Kunii (M.D., M.P.H., Ph.D.) serves Head of Strategy, Investment and Impact Division of The Global Fund to fight AIDS, Tuberculosis and Malaria, managing 5 departments, namely Strategic Information; Technical Advice and Partnership; Technical Evaluation Reference Group Secretariat; Community, Rights and Gender; Access to Funding.  He has worked more than 25 years of experience in global health, especially maternal and child health, infectious diseases control, health systems, health policy and diplomacy. He also served as Deputy Director of Aid Planning Division in the Japan Ministry of Foreign Affairs; Professor of Global Health at Nagasaki University, Research Institute of Tropical Medicine; Senior Advisor at UNICEF headquarters, Chief of Health and Child Survival Program in UNICEF Myanmar and Somalia Office.


 

#3 Dialogue: December 22, 2020  10:00-11:00am JST

Topic: “COVID-19 and Beyond: Lessons achieved under pandemic Favipiravir deployment” 

Speaker: Mr. Koichi Yamada (Corporate Vice President, Anti-Infectives Business Unit Div. FUJIFILM Toyama Chemical Co, LTD., JAPAN

Discussant: Dr. Richard H. Kaszynski (Co-founder & Director, Stanford University School of Medicine – Stanford Solutions)

Commentator: Dr. Kiyoshi Kurokawa (GHIPP)

Facilitator: Dr. Hiromi Murakami (GHIPP)

Dialogue Video is available HERE.

 

Koichi Yamada underwent his undergraduate studies at Kyoto University, then, completed his MBA at Indiana University in the U.S. He first joined FUJIFILM Corporation, where his main responsibility was in overseas marketing. Since 2012, he has been involved into the development of an anti-influenza drug candidate with the U.S. Department of Defense funding, and took part in conducting clinical studies of favipiravir in the U.S. Upon the outbreak of the Ebola fever in East Africa in 2014, after several compassionate use cases, he conducted a clinical study on Ebola patients in Guinea in corporation with the French medical team. He has been working on the administration of the above drug to COVID-19 patients, since this spring.

 

Richard H. Kaszynski is Co-founder & Director at Stanford University School of Medicine, Stanford Solutions and Executive Director at Koto Medical Tower Tokyo Japan. He has co-established various favipiravir projects including the Favipiravir Ambulatory Treatment Evaluation for Covid-19 (FATE) Trial and  A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Favipiravir Compared to Standard Supportive Care in Subjects with Mild or Asymptomatic COVID-19. He serves as a Senior Medical advisor at the Embassy of the Democratic Republic of Congo, Tokyo, Japan. Previously worked as a medical doctor at Emergency Care and Disaster Medicine Center of Tokyo Metropolitan Hospital (Hiroo), a Fellow at Harvard Medical School, Massachusetts General Hospital Department of Anesthesia, Critical Care and Pain Medicine. He earned M.D. from Kobe University and Ph.D. from Kyoto University. NHK Video Clip HERE.


#2 Dialogue: December 4, 2020  13:00-14:00 JST

Topic: “COVID-19 and Beyond: What did we learn from Japanese experience?”

Speaker: Dr. Yasuharu Tokuda (Muribushi Project for Teaching Hospitals)

Dr. Jeff Kingston (Temple University Japan)

Commentator: Dr. Kiyoshi Kurokawa (GHIPP)

Tokuda Osler Photo

Facilitator: Dr. Hiromi Murakami (GHIPP)

Dialogue Video is available HERE.

 

Yasuharu Tokuda, MD, MPH, PhD, FACP. Director and Project Leader, Muribushi Project for Teaching Hospitals, Okinawa. MPH alumni of Harvard School of Public Health. Current Affiliated Academic and Professional Appointments include Fellow of Health and Global Policy Institute, International Consultant of Taiwan Association of Hospital Medicine, Adjunct Professor of Tsukuba University, Ryukyu University, St. Marianna University, Dokkyo Medical University. Editor-in-Chief, Journal of General and Family Medicine (JGFM). Editorial Board Member, Korean Journal of Family Medicine. Recent article includes “COVID‐19 outbreak on the Diamond Princess Cruise Ship in February 2020“.

large-kingston-jeffJeff Kingston is Director of Asian Studies at Temple University Japan. Most recently he edited a 30-essay collection on the pandemic in Asia for The Asia Pacific Journal Japan Focus. His recent monographs include The Politics of Religion, Nationalism and Identity (2019) and Japan (2019), and he edited Critical Issues in Contemporary Japan (2019 and Press Freedom in Contemporary Japan (2017)) and co-edited Press Freedom in Contemporary Asia (2020) and Japan’s Foreign Relations with Asia (2018). He also wrote Nationalism in Asia: A History Since 1945 (2016) and edited Nationalisms in Asia Reconsidered (2015). His current research focuses on transitional justice and the politics of memory.


 

#1 Dialogue: November 18, 2020  9:00-10:00am JST  (November 17, 2020 19:00-20:00 EST)

Topic: “COVID-19 and Beyond: Post election US policy and potential areas for US-Japan collaborations”

Speaker: Dr. J Stephen Morrison, Senior Vice President at the Center for Strategic and International Studies (CSIS)

Commentator: Dr. Kiyoshi Kurokawa (GHIPP)Steve.Morrison.High.Res.Headshot

Facilitator: Dr. Hiromi Murakami (GHIPP)

Dialogue Video HERE.

 

 

J. Stephen Morrison is a Senior Vice President at the CSIS, where he has directed the Global Health Policy Center since he founded it in September 2008. From 2000 until 2008, he directed the CSIS Africa Program, while also launching the CSIS Task Force on HIV/AIDS (2001-2007), co-chaired by Senators John Kerry and Bill Frist. During the Clinton administration, he served on the Policy Planning Staff, under Secretaries Christopher and Albright, and prior to that, conceptualized and founded USAID’s Office of Transition Initiatives. In recent years at CSIS, Steve has directed several high-level commissions, most notably the CSIS Commission on Strengthening America’s Health Security (2018-present), and the CSIS Task Force on Women’s and Family Health (2015-2017.) He is the author of diverse analytic reports and commentaries, a frequent voice on global health, U.S. foreign policy, and international security, across a range of media. His hour-long feature documentary film, The New Barbarianism (2017) focuses on the surge of violence against the health sector in over two dozen conflicts. A new feature length documentary, The Pandemic Paradox, on the course of HIV/AIDS over the past 40 years and the risks of regression, compounded by the coronavirus pandemic, will be released in the summer of 2020. Steve received his PhD in political science at the University of Wisconsin-Madison. He is a graduate, magna cum laude, of Yale College.

 

写真右SDr. Kiyoshi Kurokawa is a professor emeritus at the National Graduate Institute for Policy Studies (GRIPS),Member of World Dementia Council (WDC), International Scientific Advisory Committee (ISAC), and Harvard T.H. Chan School of Public Health, John B. Little (JBL) Center for Radiation Sciences. After graduating from the University of Tokyo Faculty of Medicine, he served as a professor at the School of Medicine of UCLA (1979-1984), University of Tokyo (1989-1996), the dean of Tokai University School of Medicine (1996-2002), the president of the Science Council of Japan (2003-2006), the science advisor to the Prime Minister (2006-2008), World Health Organization (WHO) commissioner (2005-2009), Chair and Representative Director of Global Health Innovative Technology (GHIT: 2013.1-2018.6) and the executive member of many other national and international professional societies. He was also the chairman of the Fukushima Nuclear Accident Independent Investigation Commission by the National Diet of Japan from December 2011 to July 2012.


Organized and supported by Japan Institute for Social Innovation and Entrepreneurship (JSIE)